2026 Q2 -tulosraportti
20 päivää sitten
‧1 t 38 min
0,795 GBP/osake
Viimeisin osinko
2,14%Tuotto/v
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 5.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 27.7. | ||
2026 Q1 -tulosraportti 29.4. | ||
2025 Q4 -tulosraportti 10.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 29.7.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·5 t sittenGood Di article about the situation: https://www.di.se/analys/kaoset-ger-reapris-pa-wallenbergagda-grundbulten/
·14 t sittenAZ was my largest holding by a margin, more than 3x larger than my second largest holding. After this whole mess, I have thought a lot. 1. This acquisition/merger raises so many questions. Such an acquisition would have meant a bureaucratic nightmare, expiring patents, etc. If Astra is now in line with its goals and can deliver the results it promises for 2030, why even think along these lines? What worries me most are all the articles that have come out, describing that they were in advanced negotiations that were abandoned because the stock went down? So it was the reaction that made the board back down? Not all other circumstances regarding the deal? 2. The truth is that AZ has larger drugs losing patents going forward, the latest study was a failure. They absolutely have many more, but if they had high expectations, they wouldn't have tried to acquire. I will scale down my holding, it will still be the largest, but I want it in line with my second largest. Management has made me lower the bar and no longer think that AZ is a guaranteed case. I still believe in a nice upside going forward, but after this mess, AZ has gone from a favorite company to filling exactly the same position as the other companies in the portfolio.
The BMS story raises legitimate questions about the management's actions, but that doesn't mean AstraZeneca's fundamental case is broken. One should simply be a bit cautious with the conclusion that the acquisition plans themselves mean that management doesn't believe in organic growth. A company can believe in its own pipeline and still see strategic reasons for a larger acquisition. What we don't know is exactly what motive AZ had and what terms were discussed. I believe that the share price drop is significantly exaggerated and that there is considerable upside from here. Those who get in here and now can probably be a bit happy that management blundered.
·1 päivä sittenStock of the week. DI recommends buying Astra Zeneca. This according to info on the site Nya börssnack. Don't have a subscription to DI but it's clear it's Astra Z when reading the headline. Always something positive
Di.se gives a target price around 1880 kr, another bank gives this weekend a target price of 2200 kr, the big players have now finished buying so now we rise again.- ·2 päivää sittenLast October, the stock was down below 1400:-. Is that where we're headed? Are Americans pushing down the price to be able to take over the company cheaply? The company is still doing well and the future prospects are good, so the price is not right.
- ·2 päivää sittenBuying opportunity
My guess is that short selling positions have been taken for certainly 5 billion since the crash in July. (volume much higher than normal, clear sign of short selling as they don't stay still in a position but trade shares back and forth). Hopefully today's unjustified fall was their last push downwards and now the uptrend begins.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q2 -tulosraportti
20 päivää sitten
‧1 t 38 min
0,795 GBP/osake
Viimeisin osinko
2,14%Tuotto/v
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·5 t sittenGood Di article about the situation: https://www.di.se/analys/kaoset-ger-reapris-pa-wallenbergagda-grundbulten/
- ·14 t sittenAZ was my largest holding by a margin, more than 3x larger than my second largest holding. After this whole mess, I have thought a lot. 1. This acquisition/merger raises so many questions. Such an acquisition would have meant a bureaucratic nightmare, expiring patents, etc. If Astra is now in line with its goals and can deliver the results it promises for 2030, why even think along these lines? What worries me most are all the articles that have come out, describing that they were in advanced negotiations that were abandoned because the stock went down? So it was the reaction that made the board back down? Not all other circumstances regarding the deal? 2. The truth is that AZ has larger drugs losing patents going forward, the latest study was a failure. They absolutely have many more, but if they had high expectations, they wouldn't have tried to acquire. I will scale down my holding, it will still be the largest, but I want it in line with my second largest. Management has made me lower the bar and no longer think that AZ is a guaranteed case. I still believe in a nice upside going forward, but after this mess, AZ has gone from a favorite company to filling exactly the same position as the other companies in the portfolio.The BMS story raises legitimate questions about the management's actions, but that doesn't mean AstraZeneca's fundamental case is broken. One should simply be a bit cautious with the conclusion that the acquisition plans themselves mean that management doesn't believe in organic growth. A company can believe in its own pipeline and still see strategic reasons for a larger acquisition. What we don't know is exactly what motive AZ had and what terms were discussed. I believe that the share price drop is significantly exaggerated and that there is considerable upside from here. Those who get in here and now can probably be a bit happy that management blundered.
- ·1 päivä sittenStock of the week. DI recommends buying Astra Zeneca. This according to info on the site Nya börssnack. Don't have a subscription to DI but it's clear it's Astra Z when reading the headline. Always something positiveDi.se gives a target price around 1880 kr, another bank gives this weekend a target price of 2200 kr, the big players have now finished buying so now we rise again.
- ·2 päivää sittenLast October, the stock was down below 1400:-. Is that where we're headed? Are Americans pushing down the price to be able to take over the company cheaply? The company is still doing well and the future prospects are good, so the price is not right.
- ·2 päivää sittenBuying opportunityMy guess is that short selling positions have been taken for certainly 5 billion since the crash in July. (volume much higher than normal, clear sign of short selling as they don't stay still in a position but trade shares back and forth). Hopefully today's unjustified fall was their last push downwards and now the uptrend begins.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 5.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 27.7. | ||
2026 Q1 -tulosraportti 29.4. | ||
2025 Q4 -tulosraportti 10.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 29.7.2025 |
2026 Q2 -tulosraportti
20 päivää sitten
‧1 t 38 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 5.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 27.7. | ||
2026 Q1 -tulosraportti 29.4. | ||
2025 Q4 -tulosraportti 10.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 29.7.2025 |
0,795 GBP/osake
Viimeisin osinko
2,14%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·5 t sittenGood Di article about the situation: https://www.di.se/analys/kaoset-ger-reapris-pa-wallenbergagda-grundbulten/
- ·14 t sittenAZ was my largest holding by a margin, more than 3x larger than my second largest holding. After this whole mess, I have thought a lot. 1. This acquisition/merger raises so many questions. Such an acquisition would have meant a bureaucratic nightmare, expiring patents, etc. If Astra is now in line with its goals and can deliver the results it promises for 2030, why even think along these lines? What worries me most are all the articles that have come out, describing that they were in advanced negotiations that were abandoned because the stock went down? So it was the reaction that made the board back down? Not all other circumstances regarding the deal? 2. The truth is that AZ has larger drugs losing patents going forward, the latest study was a failure. They absolutely have many more, but if they had high expectations, they wouldn't have tried to acquire. I will scale down my holding, it will still be the largest, but I want it in line with my second largest. Management has made me lower the bar and no longer think that AZ is a guaranteed case. I still believe in a nice upside going forward, but after this mess, AZ has gone from a favorite company to filling exactly the same position as the other companies in the portfolio.The BMS story raises legitimate questions about the management's actions, but that doesn't mean AstraZeneca's fundamental case is broken. One should simply be a bit cautious with the conclusion that the acquisition plans themselves mean that management doesn't believe in organic growth. A company can believe in its own pipeline and still see strategic reasons for a larger acquisition. What we don't know is exactly what motive AZ had and what terms were discussed. I believe that the share price drop is significantly exaggerated and that there is considerable upside from here. Those who get in here and now can probably be a bit happy that management blundered.
- ·1 päivä sittenStock of the week. DI recommends buying Astra Zeneca. This according to info on the site Nya börssnack. Don't have a subscription to DI but it's clear it's Astra Z when reading the headline. Always something positiveDi.se gives a target price around 1880 kr, another bank gives this weekend a target price of 2200 kr, the big players have now finished buying so now we rise again.
- ·2 päivää sittenLast October, the stock was down below 1400:-. Is that where we're headed? Are Americans pushing down the price to be able to take over the company cheaply? The company is still doing well and the future prospects are good, so the price is not right.
- ·2 päivää sittenBuying opportunityMy guess is that short selling positions have been taken for certainly 5 billion since the crash in July. (volume much higher than normal, clear sign of short selling as they don't stay still in a position but trade shares back and forth). Hopefully today's unjustified fall was their last push downwards and now the uptrend begins.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt